Stay updated on AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.5 was added to the study’s history and the previous revision v3.5.4 was removed from the list, updating the visible version trail.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new Revision: v3.5.4 was added to the Study Record Versions. The previous Revision: v3.5.3 was removed from the list.SummaryDifference0.1%

- Check37 days agoChange DetectedThe Record History shows a new latest revision of v3.5.3, replacing v3.5.2, indicating the study record has been updated.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the version history.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.2%

- Check80 days agoChange DetectedRecord History shows multiple version updates to the study record, including changes to Recruitment Status, Study Design, Outcome Measures, and Contacts/Locations, with a 'Quality Control Review Has Not Concluded' notice.SummaryDifference0.1%

Stay in the know with updates to AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.